ArticleSensors (Basel, Switzerland)2023
Hepatocellular Carcinoma Recognition from Ultrasound Images Using Combinations of Conventional and Deep Learning Techniques.
Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Pioneering efficient deep learning architectures for enhanced hepatocellular carcinoma prediction and clinical translation.World journal of gastrointestinal oncology · 2026Article
- Preoperative prediction of early recurrence and microvascular invasion in hepatocellular carcinoma using conventional ultrasound, elastography, and clinical nutritional indicators: a radiomics-based study.American journal of translational research · 2026Article
- Advancements in artificial intelligence applications for liver ultrasound imaging.BJR artificial intelligence · 2026Review
- Progress in the Application of Artificial Intelligence in Ultrasound-Assisted Medical Diagnosis.Bioengineering (Basel, Switzerland) · 2025Review
- The power of deep learning in simplifying feature selection for hepatocellular carcinoma: a review.BMC medical informatics and decision making · 2024Review
- Malignancy diagnosis of liver lesion in contrast enhanced ultrasound using an end-to-end method based on deep learning.BMC medical imaging · 2024Article
- Deep Learning Methods in Medical Image-Based Hepatocellular Carcinoma Diagnosis: A Systematic Review and Meta-Analysis.Cancers · 2023Review
- Application and prospects of AI-based radiomics in ultrasound diagnosis.Visual computing for industry, biomedicine, and art · 2023Review
- Radiological Diagnosis of Chronic Liver Disease and Hepatocellular Carcinoma: A Review.Journal of medical systems · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Hepatocellular Carcinoma (HCC) is the most frequent malignant liver tumor and the third cause of cancer-related deaths worldwide. For many years, the golden standard for HCC diagnosis has been the needle biopsy, which is invasive and carries risks. Computerized methods are due to achieve a noninvasive, accurate HCC detection process based on medical images. We developed image analysis and recognition methods to perform automatic and computer-aided diagnosis of HCC. Conventional approaches that combined advanced texture analysis, mainly based on Generalized Co-occurrence Matrices (GCM) with traditional classifiers, as well as deep learning approaches based on Convolutional Neural Networks (CNN) and Stacked Denoising Autoencoders (SAE), were involved in our research. The best accuracy of 91% was achieved for B-mode ultrasound images through CNN by our research group. In this work, we combined the classical approaches with CNN techniques, within B-mode ultrasound images. The combination was performed at the classifier level. The CNN features obtained at the output of various convolution layers were combined with powerful textural features, then supervised classifiers were employed. The experiments were conducted on two datasets, acquired with different ultrasound machines. The best performance, above 98%, overpassed our previous results, as well as representative state-of-the-art results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.